ManojPillaiMD
Hematology • New Haven, CTHematologic Oncology
Associate Professor of Medicine, Yale University School of Medicine
Dr. Pillai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 George Street
Suite 786B
New Haven, CT 06511Phone+1 203-737-6403
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2002 - 2005
Baylor College of MedicineResidency, Internal Medicine, 1999 - 2002
All India Institute of Medical SciencesClass of 1998
Certifications & Licensure
CT State Medical License 2013 - 2025
CO State Medical License 2008 - 2015- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 145 citationsFibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen.Heather M. Brechbuhl, Jessica Finlay-Schultz, Tomomi M. Yamamoto, Austin E. Gillen, Diana M. Cittelly
Clinical Cancer Research. 2017-04-01 - 52 citationsA Randomized Double-Blind Placebo-Controlled Phase IIB Trial of Curcumin in Oral Leukoplakia.Moni Abraham Kuriakose, Kunnambath Ramdas, Bindu Dey, Subramanya Iyer, Gunaseelan Rajan
Cancer Prevention Research. 2016-08-01 - 162 citationsAntitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modula...Chandrasekhar S. Divya, M. Radhakrishna Pillai
Molecular Carcinogenesis. 2006-05-01
Abstracts/Posters
- Immune Checkpoint Inhibitor Therapy for Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes: A Single-Center ExperienceManoj M Pillai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- U2AF1 Driver Mutations in Hematopoietic Disorders Alter but Do Not Abrogate RNA Binding and Enlighten Structural Dependencies of the U2AF-RNA ComplexManoj M Pillai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- SF3B1 Mutations Induce Oncogenic IRAK4 Isoforms and Activate Targetable Innate Immune Pathways in MDS and AMLManoj M Pillai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
External Links
- Pillai Labhttp://medicine.yale.edu/lab/pillai/index.aspx
- Manoj Pillaihttp://medicine.yale.edu/lab/pillai/people//manoj_pillai.profile?source=news
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
